Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Benazin is indicated for the treatment of chorea associated with Huntington's disease.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Tetrabenazine was originally developed as an antipsychotic, but today it is mainly used to relieve symptoms of various hyperkinetic movement disorders. It works as a vesicular monoamine transporter-2 (VMAT-2) inhibitor and is used specifically to treat chorea associated with Huntington's disease.

Pregnancy & Breastfeeding

Pregnancy: There isn't enough evidence to know whether Tetrabenazine poses a developmental risk if taken during pregnancy.

Breastfeeding: It isn't known whether Tetrabenazine or its breakdown products pass into breast milk.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Recommended dosing for Tetrabenazine: Tetrabenazine can be taken with or without food. Individualization of dose with careful weekly titration is required. 1st week's starting dose: 12.5 mg daily. 2nd week: 25 mg (12.5 mg twice daily). Then slowly titrate at weekly intervals by 12.5 mg to a tolerated done that reduces chorea. Doses of 37.5 mg and up to 50 mg per day should be administered in three divided doses per day with a maximum recommended single dose not to exceed 25 mg. Patients requiring doses above 50 mg per day should be genotyped for the drug-metabolizing enzyme CYP2D6 to determine if the patient is a poor metabolizer or an extensive metabolizer. Maximum daily dose in poor metabolizers: 50 mg with a maximum single dose of 25 mg. Maximum daily dose in Extended and intermediate metabolizers: 100 mg with a maximum single dose of 37.5 mg. If serious adverse reactions occur, titration should be stopped and the dose should be reduced. If the adverse reactions do not resolve, consider withdrawal of Tetrabenazine. Pediatric & geriatric use: Safety and effectiveness in pediatric patients have not been established. The pharmacokinetics of Tetrabenazine and its primary metabolites have not been formally studied in geriatric subjects.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.

Key Interactions

Checker →